These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

405 related items for PubMed ID: 19359173

  • 1. Exploring bis-(indolyl)methane moiety as an alternative and innovative CAP group in the design of histone deacetylase (HDAC) inhibitors.
    Giannini G, Marzi M, Marzo MD, Battistuzzi G, Pezzi R, Brunetti T, Cabri W, Vesci L, Pisano C.
    Bioorg Med Chem Lett; 2009 May 15; 19(10):2840-3. PubMed ID: 19359173
    [Abstract] [Full Text] [Related]

  • 2. Design, synthesis, and evaluation of isoindolinone-hydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors.
    Lee S, Shinji C, Ogura K, Shimizu M, Maeda S, Sato M, Yoshida M, Hashimoto Y, Miyachi H.
    Bioorg Med Chem Lett; 2007 Sep 01; 17(17):4895-900. PubMed ID: 17588744
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Synthesis and structure-activity relationship of histone deacetylase (HDAC) inhibitors with triazole-linked cap group.
    Chen PC, Patil V, Guerrant W, Green P, Oyelere AK.
    Bioorg Med Chem; 2008 May 01; 16(9):4839-53. PubMed ID: 18397827
    [Abstract] [Full Text] [Related]

  • 6. Design, synthesis, and evaluation of cyclic amide/imide-bearing hydroxamic acid derivatives as class-selective histone deacetylase (HDAC) inhibitors.
    Shinji C, Maeda S, Imai K, Yoshida M, Hashimoto Y, Miyachi H.
    Bioorg Med Chem; 2006 Nov 15; 14(22):7625-51. PubMed ID: 16877001
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Identification of a series of substituted 2-piperazinyl-5-pyrimidylhydroxamic acids as potent histone deacetylase inhibitors.
    Angibaud P, Van Emelen K, Decrane L, van Brandt S, Ten Holte P, Pilatte I, Roux B, Poncelet V, Speybrouck D, Queguiner L, Gaurrand S, Mariën A, Floren W, Janssen L, Verdonck M, van Dun J, van Gompel J, Gilissen R, Mackie C, Du Jardin M, Peeters J, Noppe M, Van Hijfte L, Freyne E, Page M, Janicot M, Arts J.
    Bioorg Med Chem Lett; 2010 Jan 01; 20(1):294-8. PubMed ID: 19906529
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and biological evaluation of 3-(4-substituted-phenyl)-N-hydroxy-2-propenamides, a new class of histone deacetylase inhibitors.
    Kim DK, Lee JY, Kim JS, Ryu JH, Choi JY, Lee JW, Im GJ, Kim TK, Seo JW, Park HJ, Yoo J, Park JH, Kim TY, Bang YJ.
    J Med Chem; 2003 Dec 18; 46(26):5745-51. PubMed ID: 14667227
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. New pyrrole-based histone deacetylase inhibitors: binding mode, enzyme- and cell-based investigations.
    Mai A, Valente S, Nebbioso A, Simeoni S, Ragno R, Massa S, Brosch G, De Bellis F, Manzo F, Altucci L.
    Int J Biochem Cell Biol; 2009 Jan 18; 41(1):235-47. PubMed ID: 18834955
    [Abstract] [Full Text] [Related]

  • 14. Design and synthesis of novel isoxazole-based HDAC inhibitors.
    Conti P, Tamborini L, Pinto A, Sola L, Ettari R, Mercurio C, De Micheli C.
    Eur J Med Chem; 2010 Sep 18; 45(9):4331-8. PubMed ID: 20637529
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Improved antiproliferative activity of 1,3,4-thiadiazole-containing histone deacetylase (HDAC) inhibitors by introduction of the heteroaromatic surface recognition motif.
    Guan P, Wang L, Hou X, Wan Y, Xu W, Tang W, Fang H.
    Bioorg Med Chem; 2014 Nov 01; 22(21):5766-75. PubMed ID: 25311567
    [Abstract] [Full Text] [Related]

  • 18. New aryldithiolethione derivatives as potent histone deacetylase inhibitors.
    Tazzari V, Cappelletti G, Casagrande M, Perrino E, Renzi L, Del Soldato P, Sparatore A.
    Bioorg Med Chem; 2010 Jun 15; 18(12):4187-94. PubMed ID: 20576572
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Exploring the pharmacokinetic properties of phosphorus-containing selective HDAC 1 and 2 inhibitors (SHI-1:2).
    Heidebrecht RW, Chenard M, Close J, Dahlberg WK, Fleming J, Grimm JB, Hamill JE, Harsch A, Haines BB, Hughes B, Kral AM, Middleton RE, Mushti C, Ozerova N, Szewczak AA, Wang H, Wilson K, Witter DJ, Secrist JP, Miller TA.
    Bioorg Med Chem Lett; 2009 Apr 01; 19(7):2053-8. PubMed ID: 19268585
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.